Paper33713600
Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer.
Tailor D and 14 others. Cell Chem Biol, 2021. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer. Papers, record 33713600. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33713600
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Ovarian Neoplasms | Major topic |
| Y-Box-Binding Protein 1 | Major topic |
| Aged | |
| Animals | |
| Apoptosis | |
| Cell Line | |
| Cell Movement | |
| Cell Proliferation | |
| Cell Survival | |
| Drug Screening Assays, Antitumor | |
| Female | |
| Humans | |
| Middle Aged | |
| Molecular Structure | |
| Rats |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA124435 | NCI NIH HHS | United States | P30CA124435 | PubMed | NIH RePORTER |
| T32 CA121940 | NCI NIH HHS | United States | T32CA121940 | PubMed and NIH | NIH RePORTER |
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24767708 | Ovarian cancer. | Lancet | 2014 | https://conductscience.org/library/papers/24767708 | PubMed |
| 2 | 29232469 | Acquired chemotherapy resistance in ovarian cancer. | Ann Oncol | 2017 | https://conductscience.org/library/papers/29232469 | PubMed |
| 3 | 2873780 | Taxol: mechanisms of action and resistance. | Ann N Y Acad Sci | 1986 | https://conductscience.org/library/papers/2873780 | PubMed |
| 4 | 23641145 | YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression. | Transl Oncogenomics | 2007 | https://conductscience.org/library/papers/23641145 | PubMed |
| 5 | 24100801 | Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube. | Arch Gynecol Obstet | 2014 | https://conductscience.org/library/papers/24100801 | PubMed |
| 6 | 9506530 | Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids. | Int J Cancer | 1998 | https://conductscience.org/library/papers/9506530 | PubMed |
| 7 | 7859748 | Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. | EMBO J | 1995 | https://conductscience.org/library/papers/7859748 | PubMed |
| 8 | 30422115 | Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13. | Elife | 2018 | https://conductscience.org/library/papers/30422115 | PubMed |
| 9 | 25957686 | Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement. | Cell | 2015 | https://conductscience.org/library/papers/25957686 | PubMed |
| 10 | 27923830 | A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers. | Cancer Res | 2017 | https://conductscience.org/library/papers/27923830 | PubMed |
| 11 | 30342537 | Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs. | Mol Cancer | 2018 | https://conductscience.org/library/papers/30342537 | PubMed |
| 12 | 12835670 | Ovarian cancer: strategies for overcoming resistance to chemotherapy. | Nat Rev Cancer | 2003 | https://conductscience.org/library/papers/12835670 | PubMed |
| 13 | 26200936 | Applications of Fluorine in Medicinal Chemistry. | J Med Chem | 2015 | https://conductscience.org/library/papers/26200936 | PubMed |
| 14 | 11325824 | Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. | Cancer Res | 2001 | https://conductscience.org/library/papers/11325824 | PubMed |
| 15 | 24335958 | Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. | Cancer Res | 2014 | https://conductscience.org/library/papers/24335958 | PubMed |
| 16 | 15542787 | The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. | Mol Cancer Ther | 2004 | https://conductscience.org/library/papers/15542787 | PubMed |
| 17 | 9704408 | Gene regulation by Y-box proteins: coupling control of transcription and translation. | Trends Cell Biol | 1998 | https://conductscience.org/library/papers/9704408 | PubMed |
| 18 | 27013200 | Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway. | Cancer Res | 2016 | https://conductscience.org/library/papers/27013200 | PubMed |
| 19 | 8102521 | Biochemistry of multidrug resistance mediated by the multidrug transporter. | Annu Rev Biochem | 1993 | https://conductscience.org/library/papers/8102521 | PubMed |
| 20 | 1701014 | Poly(A) tail shortening is the translation-dependent step in c-myc mRNA degradation. | Mol Cell Biol | 1990 | https://conductscience.org/library/papers/1701014 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42698848 | YBX1 as an adaptive RNA hub in cancer: linking state-dependent RNA regulation to tumor immunity, metabolic reprogramming, and therapy resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42698848 | PubMed |
| 42662718 | Prioritizing Candidate YB‑1 Cold Shock Domain Ligands via 5D-ElectroShape and Boltz Generative Cofolding. | ACS Omega | 2026 | https://conductscience.org/library/papers/42662718 | PubMed |
| 42523350 | Nuclear translocation of phosphorylated YB-1 via small extracellular vesicles contributes to the malignant phenotype of triple negative breast cancer. | bioRxiv | 2026 | https://conductscience.org/library/papers/42523350 | PubMed |
| 42314682 | Quantitative molecular cartography of emergency myelopoiesis reveals conserved modules of hematopoietic activation. | Cell Stem Cell | 2026 | https://conductscience.org/library/papers/42314682 | PubMed |
| 42033033 | Y-box binding protein-1 at the crossroads of DNA damage response and tumor immune evasion. | JNCI Cancer Spectr | 2026 | https://conductscience.org/library/papers/42033033 | PubMed |
| 41994112 | YBX1 Promotes Drug Resistance in Hepatocellular Carcinoma and Serves as a Potential Therapeutic Target. | Res Sq | 2026 | https://conductscience.org/library/papers/41994112 | PubMed |
| 41993887 | In Silico Analysis of Potential Stabilizer Binding Sites at Protein-RNA Interfaces. | Comput Struct Biotechnol J | 2026 | https://conductscience.org/library/papers/41993887 | PubMed |
| 41909745 | Targeting RNA binding proteins with small-molecule inhibitors: Advances, challenges, and therapeutic opportunities. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41909745 | PubMed |
| 41596179 | Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41596179 | PubMed |
| 41557215 | Discovery of a Novel Small-Molecule Modulator for Full-length YB-1 Protein via Integrated Computational and in vitro Biophysical Approaches. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/41557215 | PubMed |
| 41214061 | Investigating prognostic features in high-grade serous ovarian cancer through gene regulatory network inference with single-cell transcriptomic profiles. | Sci Rep | 2025 | https://conductscience.org/library/papers/41214061 | PubMed |
| 41205595 | Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancer. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/41205595 | PubMed |
| 41070608 | Multifaceted functions of Y‑box binding protein 1 in RNA methylated modifications (Review). | Mol Med Rep | 2025 | https://conductscience.org/library/papers/41070608 | PubMed |
| 41025501 | YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomas. | Neuro Oncol | 2026 | https://conductscience.org/library/papers/41025501 | PubMed |
| 40846998 | α-Ketoglutarate dictates AMPK protein synthesis for energy sensing in human cancers. | Nat Chem Biol | 2026 | https://conductscience.org/library/papers/40846998 | PubMed |
| 40814288 | The dual role of RNA-binding proteins: promotion of tumorigenesis, drug resistance, and emerging therapeutic targets. | Acta Biochim Biophys Sin (Shanghai) | 2025 | https://conductscience.org/library/papers/40814288 | PubMed |
| 40716510 | Transcription factor YBX1 orchestrates drug resistance and tumor progression in HCC. | Drug Discov Today | 2025 | https://conductscience.org/library/papers/40716510 | PubMed |
| 40216969 | KPNA2 promotes osteosarcoma progression by regulating the alternative splicing of DDX3X mediated by YBX1. | Oncogene | 2025 | https://conductscience.org/library/papers/40216969 | PubMed |
| 40044536 | Ribosome-directed cancer therapies: the tip of the iceberg? | Trends Pharmacol Sci | 2025 | https://conductscience.org/library/papers/40044536 | PubMed |
| 39565541 | Integrative Investigation of Flavonoids Targeting YBX1 Protein-Protein Interaction Network in Breast Cancer: From Computational Analysis to Experimental Validation. | Mol Biotechnol | 2025 | https://conductscience.org/library/papers/39565541 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| YBX1 | 4904 | PubTator's text mining | https://conductscience.org/library/genes/4904 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33713600
GET https://conductscience.org/api/papers/v1/33713600/references?page=2